Extracellular matrix fragments as regulators of cartilage metabolism in health and disease

Current Rheumatology Reviews

Volumn 3, Issue 3, 2007, Pages 183-196

  Homandberg, Gene A ^a   Ding, Lei ^a   Guo, Danping ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cartilage; Fibronectin; Fibronectin fragments; Matrix; Osteoarthritis

Indexed keywords

COLLAGEN TYPE 2; CYTOKINE; FIBRONECTIN; HYALURONIC ACID; INTEGRIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE; PROTEOGLYCAN;

ANKLE; BIOSYNTHESIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CATABOLISM; CELL ACTIVITY; CELL DAMAGE; CELL INTERACTION; CELL PROTECTION; CHONDROLYSIS; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HUMAN; KNEE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE METABOLISM; TISSUE REGENERATION; UPREGULATION;

EID: 34548299101     PISSN: 15733971     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339707781387590     Document Type: Review

References (141)

1. Homandberg GA. Potential Regulation of Cartilage Metabolism in Osteoarthritis by Fibronectin Fragments. In Special Issue "Fundamental Pathways in Osteoarthritis" in journal, Frontiers in Bioscience 4, d713-730, October, 15, 1999 [ed. Charles J. Malemud].
2. Homandberg GA. Cartilage Damage by Matrix Degradation Products: Fibronectin Fragments. In Clinical Orthopaedics and Related Research 391S, pp S100-S107, 2001 [eds. Lippincott Williams and Wilkins, Inc].
3. Knudson W, Loeser RF. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 2002; 59: 36-44.
4. Knudson CB, Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism, Clin Orthop Relat Res 2004; 427(Suppl): S152-162.
5. Miller DR, Mankin HJ, Shoji HD. D'Ambrosia A. Identification of fibronectin in preparations of osteoarthritic articular cartilage. Connect Tissue Res 1984; 12: 267-75.
6. Brown RA, Jones KL. Fibronectin synthesis and release in normal and osteoarthritic human articular cartilage. Eur J Exp Musculoskel Res 1992; 1: 25-32.
7. Wurster NB, Lust G. Synthesis of fibronectin in normal and osteoarthritis cartilage. Biochim Biophys Acta 1984; 800: 52-8.
8. Burton-Wuster N, Lust G. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints. Am J Vet Res 1985; 46: 2542-5.
9. Burton-Wurster N, Butler M, Harter S, et al. Presence of fibronectin in articular cartilage in two animal models of osteoarthritis. J Rheumatol 1986; 13: 175-82.
10. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1981; 40: 142-53.
11. Carnemolla B, Cutolo M, Castellani P, Balza E,. Raffanti S, Zardi L. Characterization of synovial fluid fibronectin from patients with inflammatory diseases and healthy subjects, Arthritis Rheum 1984; 27: 913-21.
12. Farquhar T, Xia Y, Mann K, et al. Swelling and fibronectin accumulation in articular cartilage explants after cyclical impact. J Orthop Res 1996; 14: 417-23.
13. Steinmeyer J, Ackermann B, Raiss R. Intermittent cyclic loading of cartilage explants modulates fibronectin metabolism. Osteoarthr Cartil 1997; 5: 331-41.
14. Burton-Wurster N, Vernier-Singer M, Farquhar T, Lust G. Effect of compressive loading and unloading on the synthesis of total protein, proteoglycan and fibronectin by canine cartilage explants. J Orthop Res 1993; 11: 717-29.
15. Griffiths AM, Herbert, KA, Perrett D, Scot DL. Fragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexes. Clin Chima Acta 1989; 184: 133-46.
16. Clemmensen I, andersen RB. Different molecular forms of fibronectin in rheumatoid synovial fluid. Arthritis Rheum 1982; 25: 25-31.
17. Xie DL, Meyers R, Homandberg GA. Fibronectin fragments in osteoarthritic synovial fluid, J Rheumatol 1992; 19: 1448-52.
18. Homandberg GA, Hui F, Wen C. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluids, Osteoarthr Cartil 1998; 6: 231-44.
19. Zack MD, Amer EC, Anglin CP, Alston JT, Malfait AM, Tortorella MD. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum. 2006; 54: 2912-22.
20. Wysocki AB, Grinnell F. Fibronectin Profiles in Normal and chronic wound fluid. Lab Invest 1990; 63: 825-31.
21. LaCelle P, Blumenstock FA, Saba TM. Blood-borne fragments of fibronectin after thermal injury. Blood 1991; 77: 2037-41.
22. Carsons S. High levels of fibronectin fragments in the plasma of a patient with active systemic lupus erythematosus. J Rheumatol 1987; 14: 1052-4.
23. Easter DW, Hoyt DB, Ozkan AN. Immunosuppression by a peptide from the gelatin binding domain of human fibronectin. J Surg Res 1988: 45: 370-5.
24. Allal M, Robert L, Labat-Robert J. Fragmentation of fibronectin in cystic fibrosis. C R Acad Sci III 1992; 314: 587-92.
25. Skrha J, Vackova I, Kvasnicka J, et al. Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type I diabetes mellitus. Eur J Clin Invest 1990; 20: 171-6.
26. Suzuki K, Ono T, Umeda M, Itoh H. Secretion of ceft-adhesion-promoting factors, fibronectin, fibronectin fragments and a 53-kDa protein, by human rectal adenocarcinoma, cells. Int J Cancer 1992; 52: 818-6.
27. Trial J, Rubio JA, Birdsall HH, Rodriquez-Barradas M, Rossen RD. Monocyte activation by circulating fibronectin fragments in HIV-1 infected patients. J Immunol 2004; 173: 2190-8.
28. Hino K, Shiozawa S, Kuroki Y, et al. EDA-containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 1995; 38: 678-83.
29. Rencic A, Gehris AL, Lewis SD, Hume EL, Bennett VD. Splicing patterns of fibronectin mRNAs from normal and osteoarthritic human articular cartilage. Osteoarthr Cartil 1995; 3: 187-96.
30. Burton-Wurster N, Lust G, Macleod JN. Cartilage fibronectin isoforms: in search of functions for a special population of matrix glycoproteins. Matrix Biol 1997; 15: 441-54.
31. Zhang D, Burton-Wurster N, Lust G. Antibody specific for extra domain B of fibronectin demonstrates elevated levels of both extra domain B(+) and B(-) fibronectin in osteoarthritic canine cartilage. Matrix Biol 1995; 14: 623-33.
32. Mehraban F, Lark MW, Ahmed FN, Xu F, Moskowitz RW. Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis. Osteoarthri Cart 1998; 6: 286-94.
33. Lorenzo P, Bayliss MT, Neinegard D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis, Matrix Biol 2004; 23: 381-91.
34. Squires GR, Okeouneff S, Ionescu M, Poole AR. The pathobiology of focal lesion development in aging articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 2003; 48: 1261-70.
35. Felice BR, Chichester CO, Barrach HJ. Type II Collagen Peptide release from rabbit articular cartilage. Ann NY Acd Sci 1999; 878: 590-3.
36. Billingburst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1987; 99: 1534-45.
37. Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 1991; 266: 5625-8.
38. Reijman M, Hazes JM, Bierma-Zeinstra SM, et al. A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 2004; 50: 2471-8.
39. Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 2004; 71: 70-6.
40. Christgau S, Henrotin Y, Tanko LB, et al. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin Exp Rheumatol 2004; 22: 36-42.
41. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis, Arthritis Rheum 2003; 48: 3130-9.
42. Lindhorst E, Wachasmuth L, Kimmig N, et al. Increase in degraded type II collagen in synovial fluid early in the rabbit meniscectomy model of osteoarthritis. Osteoarthr Cartil 2005; 13: 139-45.
43. Sharif M, George E, Shepstone L, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995; 38: 760-7.
44. Manicourt DH, Cornu O, Lenz ME, Druetz-van Egeren A, Thonar EJ. Rapid and sustained rise in the serum level of hyaluronan after anterior cruciate ligament transaction in the dog knee joint. J Rheumatol 1995; 22: 262-9.
45. O'Byrne EM, Schroder HC, Stefano C, Goldberg RL. Catabolin/interleukin-1 regulation of cartilage and chondrocyte metabolism, Agents Actions 1987; 21: 341-4.
46. Kolibas LM, Goldberg, RL. Effects of cytokines and anti-arthritic drugs on glycosaminoglycan synthesis by bovine articular chondrocytes. Agents Actions 1989; 27: 245-9.
47. Lees VC, Fan TP, West CD. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 1995; 73: 259-66.
48. Ohno-Nakahara M, Honda K, Tanimoto K, et al. Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J Biochem 2004; 135: 567-75.
49. McKenna LA, Liu H, Sansom PA, Dean MF. An N-terminal peptide from link protein stimulates proteoglycan biosynthesis in human articular cartilage in vitro, Arthritis Rheum 1998; 41: 157-62.
50. Liu H, McKenna LA, Dean MF. An N-terminal peptide from link protein can stimulate biosynthesis of collagen by human articular cartilage. Arch Biochem Biophys 2000; 378: 116-22.
51. Dean MF, Lee YW, Dastjerdi AM, Lees P. The effect of link peptide on proteoglycan synthesis in equine articular cartilage. Biochim Biophys Acta 2003; 1622:161-8.
52. Homandberg GA, Hui F. High concentrations of fibronectin fragments cause short term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys 1994; 311: 213-8.
53. Homandberg GA, Wen C. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage. J Orthop Res 1998; 16: 237-46.
54. Homandberg GA, Meyers R, Xie DL. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992; 267: 3597-604.
55. Xie D-L, Homandberg GA. Fibronectin fragments bind to and penetrate cartilage tissue resulting in protease expression and cartilage damage. Biochim Biophys Acta 1993; 1182: 189-96.
56. Xie DL, Hui F, Meyers R, Homandberg GA. Cartilage Chondrolysis by Fibronectin Fragments is Associated with Release of Several Proteinases: Stromelysin Plays a Major Role in Chondrolysis. Arch Biochem Biophys 1994; 311: 205-12.
57. Xie DL, Hui F, Homandberg GA. Fibronectin fragments alter matrix protein synthesis in cartilage cultured in vitro. Arch Biochem Biophys 1993; 307: 110-8.
58. Homandberg GA, Hui F, Wen, C. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys 1996; 334: 325-31.
59. Homandberg GA, Hui F, Wen C, et al. Fibronectin fragment induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J 1997; 321: 751-7.
60. Bewsey Y, Wen C, Purple C, Homandberg GA. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture. Biochim Biophys Acta 1996; 1317: 55-64.
61. Homandberg GA, Hui F, Manigalis C, Shrikhande A. Cartilage chondrolysis caused by fibronectin fragments causes cleavage of aggrecan at the same sites as in osteoarthritis. Osteoarthr Cartil 1997; 5: 450-3.
62. Kang Y, Eger W, Koepp H, Williams JM, Kuettner KE, Homandberg GA. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthop Res 1999; 17: 858-69.
63. Forsyth CB, Pulai J, Loeser RF. Fibronectin fragments and blocking antibodies to alpha2betal and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase cotlagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002; 46: 2368-76.
64. Pichika R, Homandberg GA. Fibronoctin Fragments Elevate Nitric Oxide (NO) and Inducible No Synthetase (iNOS) Levels In Bovine Cartilage and INOS Inhibitors Block Fibronectin Fragment Mediated Damage and Promote Repair. Inflamm Res 2004; 53: 405-12.
65. Yasuda T, Poole AR, Shimizu M, et al. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding-fragment of fibronectin in human articular cartilage in culture. Arthritis-Rheum 2003; 48: 1271-80.
66. Purple CR, Untermann TG, Pichika R, Homandberg GA. Fibronectin Fragments Upregulate Insulin-like Growth Factor Binding Proteins in Chondrocytes. Osteoarthr Cartil 2002; 10: 734-46.
67. Su SL, Tsai CD, Lee CH, Salter DM, Lee HS. Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes. Osteoarthr Cartil 2005; 13: 879-86.
68. Chow, G, Knudson CB, Homandberg GA, Knudson W. Increased CD44 expression in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem 1995; 270: 27734-41.
69. Saito S, Yamaji N, Yasunaga K, et al. The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem 1999; 274: 30756-63.
70. Yasuda T, Poole AR. A fibroneoun fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 2002; 46: 138-48.
71. Stanton H, Ung L, Fosang AJ. The 45 kda collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthsis by chondrocytes and aggrecan-degradation by aggrecanases. Biochem J 2002;364: 181-90.
72. Hu B, Kapila YL, Buddhikot M, Shiga M, Kapila S. Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminoment activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1. Matrix Biol 2000; 19: 657-69.
73. Kapila YL, Kapila S, Johnson PW. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol 1996; 15: 251-61.
74. Dai R, Iwama A, Wang S, Kapila YL. Disease-associated fibronectin matrix fragments trigger anoikis of human primary ligament cells: p53 and c-myc are suppressed. Apoptosis 2005; 10: 503-12.
75. Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW. Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine 2000; 25: 2742-7.
76. anderson DG, Li X, Tannoury T, Beck G, Balian G. A fibronectin fragment stimulates intervertebral disc degeneration in vivo. Spine 2003; 28: 2338-45
77. anderson DG, LiX, Balian G. A fibronectin fragment alters the metabolism by rabbit intervertebral disc cells in vitro. Spine 2005; 30: 1242-6.
78. Aota Y, An HS, Homandberg G, et al. Differential effects of fibronectin fragment on proteoglycan metabolism by intervertebral disc cells: a comparison with articular chondrocytes. Spine 2005; 30: 722-8.
79. Pulai JI, Chen H, Im HJ, et al. NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytesn in response to fibronectin fragments. J Immunol 2005; 174: 5781-8.
80. Kamiya S, Kawaguchi T, Hasebe S, et al. A fibronectin fragment induces tumor necrosis factor production of rat basophilic leukemia cells. Biochim Biophys Acta 2004; 1675: 87-94.
81. Lopez-armada MJ, Gonzalez E, Gomez-Guerrero C, Egido J. The 80-kD fibronectin fragment increases the production of fibronectin and tumor necrosis factor alpha [TNF-alpha] in cultured mesangial cells. Clin Exp Immunol 1997; 107: 398-403.
82. Yasuda T, Shimizu M, Nakagawa T, Julovi SM, Nakamura T. Matrix metalloproteinase production by COOH-terminal heparinbinding fibronectin fragment in rheumatoid synovial cells. Lab Invest 2003; 83: 153-62.
83. Gemba T, Valbracht J, Alsalameh S, Lotz M. Focal adhesion kinase and mitogen-activated protein kinases am involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment. J Biol Chem 2002; 277: 907-11.
84. Amer EC, Tortorella MD. Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin 1. Arthritis Rheum 1995; 38: 1304-14.
85. Homandberg GA, Hui F. Arg-Gly-Asp-Ser peptide analogs suppress cartilage chondrolysis activities of integrin-binding and non-binding fibronectin fragments. Arch Biochem Biophys 1994; 310: 40-8.
86. Homandberg GA, Hui F, Wen C. Fibronectin fragment mediated cartilage chondrolysis: (I) suppression by anti-oxidants. Biochim Biophys Acta 1996; 1317: 134-42.
87. Homandberg GA, Hui F, Wen C. Fibronectin fragment mediated cartilage chondrolysis: (II) reparative effects of anti-oxidants. Biochim Biophys Acta 1996; 1317: 143-8.
88. Homandberg GA, Wen C, Hui F. Agents that block fibronectin fragment mediated cartilage damage also promote repair. Inflamm Res 1997; 46: 467-71.
89. Koepp HE, Sampath KT, Kuettner KE, Homandberg GA. Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis. Inflamm Res 1999; 48: 199-204.
90. Homandberg GA, Hui F, Williams JM, Kuettner KE. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis in vitro. Osteoathr Cartil 1997: 5: 309-19.
91. Im HI, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser RF. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronoctin fragment- and interleukin-[beta-stimulated matrix metallloproteinase-13 expression in human chondrocytes. J Biol Chem 2003: 278: 25386-94.
92. Dang YW, Cole AA, Homandberg GA. Comparison of the catabolic effects of fibronectin fragments (Fn-F) in human knee and ankle cartilages. Osteoarthr Cartil 2003: 11: 538-47.
93. Homandberg GA, Meyers R, Williams JM. Intra-articular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans In vivo. J Rheumatol 1993: 20: 1378-82.
94. Homandberg GA, Kang Y, Zhang J, Cole AA, Williams JM. A single injection of fibronectin fragments into rabbit knee joints enhances catabolism in the articular cartilage followed by reparative responses but also induces systemic effects in the non-injected joints. Osteoarthr Cartil 2001; 9: 673-83.
95. Williams JM, Plaza VL, Wen J, Karwo DG, Homandberg, GA. Short and Long Term Effects of Multiple Intrarticular Injections of Fibronectin Fragments on the Articular Cartilage of Adolescent Rabbits. Orthop Trans 1996; 21: 313.
96. Williams JM, Zhang J, Kang Y, Homandberg GA. Effect of intra-articular injection of high molecular weight hyaluronic acid in joints of skeletally mature rabbits on protection against cartilage chondrolysis induced by fibronectin fragments. Osteoarthr Cartil 2003; 11: 44-9.
97. Goto M, Yoshinoya S, Miyamoto T, et al. Stimulation of interleukin-1 alpha and interleukin-1 beta release from human monocytes by cyagnogen bromide peptides of type II collagen, Arthritis Rheum 1988; 31: 1508-14.
98. Golds EE, Poole AR. Connective tissue antigens stimulate collagenase production in arthritic diseases. Cell Immunol 1984; 86: 190-205.
99. Rice A, Banda MJ. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry 1995; 34: 9249-56.
100. Yasuda T, Mwale F, Burgess J, Poole AR. Trans Orthop Res Soc 1999; 45: 336.
101. Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1 and activates are via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 2002; 62: 5580-9.
102. Jennings L, Wu L, King KB, Hammerle H, Cs-Szabo G, Mollenhauer J. The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect Tissue Res 2001; 42: 71-86.
103. Lucic D, Mollenhauer J, Kilpatrick KE, Cole AA. N-telopeptide of type II collagen interacts with annexin V on human chondrocytes. Connect Tissue Res 2003; 44: 225-39.
104. Fichter M, Korner U, Schomburg, Jennings L, Cole AA, Mollenhauer J. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes. J Orthop Res 2006; 24: 64-70.
105. Yasuda T, Tchetina E, Ohsawa K, et al. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biol 2006; 25: 419-29.
106. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis 1: Arthritis Rheum 2000; 43: 1165-74.
107. Chow G, Nietfeld JJ, Knudson CB, Knudson W. Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthritis Rheum 1998; 41: 1411-9.
108. Knudson W, Aguiar Di, Hua Q, Knudson CB. CD44-anchored hyaluronan-rich pericellular matrices: An ultrastructural and biochemical analysis. Exp Cell Res 1996; 228: 216-28.
109. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endacytosis. J Cell Sci 1993; 106: 365-75.
110. Knudson CB. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 1993; 120: 825-34.
111. Knudson W, Bartnik E, Knudson CB. Assembly of pericellular matrices by COS-7 cells transfected with CD44 homing receptor genes. Proc Natl Acad Sci USA 1993; 90: 4003-7.
112. Ohno S, Ohno-Nakahara M, Knudson CB, Knudson W. Induction of MMP-3 by hyaturonan oligosaccharides in temporomandibular joint chondrocytes. J Dent Res 2005; 84: 1005-9.
113. Ohno S, Im HJ, Knudson CB, Knudson W. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum 2005; 52: 800-9.
114. Ohno S, Im HJ, Knudson CB, Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes, J Biol Chem 2006; 281: 17952-60.
115. Iacob S, Knudson CB. Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int J Biochem Cell Biol 2006; 38: 123-33.
116. McKee CK Penno MB, Cowman M, et al. Hyaluronan fragments induce chemokine gene expression in alveolar macrophages. J Clin Invest 1996; 98: 2403-13.
117. McKee, C M, Lowenstein, CJ, Horton, MR, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear KB-dependent mechanism. J Biol Chem 1997; 272: 8013-8.
118. Homandberg GA., Ummadi VJ, Kang H. The Role of Insulin-like Growth Factor-I in Hyaluronan Mediated Repair of Cultured Cartilage Explants. Inflamm Res 2004; 53: 396-404.
119. Lafeber FP, van Roy H, Wilbrink B, Huber-bruning O, Bijlsma JW. Human osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage. J Rheumatol 1992; 19: 123-9.
120. Mankin HJ, Johnson ME, Lipiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. Distribution and metabolism of amino sugar-containing macromolecules. J Bone Joint Surg (Am) 1981; 63: 131-9.
121. Dallas SL, Miyazono K, Skerry TN, Mundy GR, Bonewald LF. Dual role for the latent growth factor binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol 1995; 131: 539-49.
122. Luyten FP, Hascall CV, Nissley SP, Morales TI, Reddi HA. Insulin-like growth factors maintain steady state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 1988; 267: 416-25.
123. Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochern J 1989; 260: 543-8.
124. Taipale J, Koli K, Keski-Oja J. Release of transforming growth factor beta-1 from the pericellular matrix of cultured human fibroblasts and fibrosaracoma. cells by plasmin and thrombin. J Biol Chem 1992; 267: 25378-85.
125. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H. Matrix Metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994; 269: 25742-6.
126. Guan JL. Focal adhesion kinase in integrin signaling. Matrix Biol 1997; 16: 195-200.
127. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004; 1692: 103-19.
128. Kornberg L, Earp HS, Turner C, Prokop C, Juliano L. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta integrins. Proc Natl Acad Sci USA 1991; 88: 8392-6.
129. 1, expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 1995; 6: 725-40.
130. 1 integrin stimulates the expression of cyclin-dependent inases and DNA synthesis through activation of extracellular signal-regulated kinase. J Biol Chem 1998; 273: 1662-9.
131. Dalton SL, Scharf E, Briesewitz R, Marcantonio EE, Assoian RK. Cell adhesion to extracellular matrix regulates the life cycle of integrins. Mol Biol Cell 1995; 6: 1781-91.
132. Chen WT, Wang J, Hasegawa T, Yamada SS, Yamada KM. Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin and synthetic pcptides J Cell Biol 1986; 103: 1649-61.
133. Stickel SK, Wang Y-1. Synthetic peptide GRDGS induces dissociation of alpha-actinin and vinculin from the sites of focal contact. J Cell Biol 1988; 107: 1231-9.
134. Huhtala. P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH. Cooperative Signaling by alpha5beta1 and alpha4betal integrins regulate metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995; 129: 867-9.
135. Hocking DC, Sottile J, McKeown-Longo PJ. Activation of distinct alpha5beta1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains. J Cell Biol 1998; 141:2 41-53.
136. Carragher NO, Levkau B, Ross R, Raines EW. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol 1999; 147: 619-30.
137. Homandberg GA, Costa V, Wen C. Anti-Sense ohgonucleotides to the alpha5 integrin subunit suppress cartilage chondrolytic activities of amino-terminal fibronectin fragments. Ostcoarthr Cartil 2001; 10: 381-93.
138. Homandberg GA, Costa V, Wen C. Fibronectin fragments active in chondrocytic chondrolysis can be chemically crosslinked to die alpha5 intWin receptor subunit. Osteoarthr Cartil 2002; 10: 938-49.
139. Tuckwell DS, Ayad S, Grant ME, Takigawa M, Humphries MJ. Conformation dependence of integrin-type II collagen binding. Inability of collagen peptides to support alpha2beta1 binding and mediation of adhesion to denatured collagen by a novel alpha5beta1-fibronectin bridge. J Cell Sci 1994; 107: 993-1005.
140. Yasuda T, Julovi SM, Hiramitsu T, Yoshida M, Nakamura T. Requirement of mitogen-activated protein kinase for collagenase production by the fibronectin fragment in human articular chondrocytes in culture. Mod Rheumatol 2004; 14: 54-60.
141. Loeser RF, Forsyth CB, Samarel AM, Im HJ. Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 2003; 278: 24577-85.